Skip to content

Transplantation of autologous esophageal mucosa to prevent stricture after circumferential endoscopic submucosal dissection of early esophageal cancer

Transplantation of autologous esophageal mucosa to prevent stricture after circumferential endoscopic submucosal dissection of early esophageal cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040119
Enrollment
Unknown
Registered
2020-11-21
Start date
2019-01-01
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal stricture after circumferential endoscopic submucosal dissection of early esophageal cancer

Interventions

Experimental group:Autologous esophageal mucosal transplantation
The control group:Titanium clamp

Sponsors

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, LinHai, Zhejiang, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with EEC expected to result in a above 3/4-circumference or longitudinal axis length between 3-6cm post-ESD artificial ulcer; 2. Patients who can tolerate endoscopic treatment under general anesthesia; 3. Patients who agreed to participate in the clinical trial and signed informed consent for surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with eating disorders and absorption disorders caused by other reasons; 2. Patients with diabetes, autoimmune diseases, and a recent history of taking drugs such as hormones and immunosuppressant; 3. Patients with severe cardiovascular and cerebrovascular diseases, severe hepatic and renal insufficiency, and a history of severe chronic pulmonary disease; 4. Patients with acute or chronic infections.

Design outcomes

Primary

MeasureTime frame
with or without stricture occurrence;adverse events;Mucosal survival rate;Stooler grade and SF-36 score of quality of Life Evaluation Scale;Wound healing;Serum related inflammatory cytokine concentration, Masson staining results, RT-PCR and WB detection of related molecule expression;

Countries

China

Contacts

Public ContactXingli Mao

Taizhou Hospital of Zhejiang Province

maoxl@enzemed.com+86 13566866269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026